A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma

Prasong Khaenam, Darawan Rinchai, Matthew C. Altman, Laurent Chiche, Surachat Buddhisa, Chidchamai Kewcharoenwong, Duangchan Suwannasaen, Michael Mason, Elizabeth Whalen, Scott Presnell, Wattanachai Susaengrat, Kimberly O'Brien, Quynh Ahn Nguyen, Vivian Gersuk, Peter S. Linsley, Ganjana Lertmemongkolchai, Damien J. Chaussabel

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: There are diverse molecules present in blood plasma that regulate immune functions and also present a potential source of disease biomarkers and therapeutic targets. Genome-wide profiling has become a powerful method for assessing immune responses on a systems scale, but technologies that can measure the plasma proteome still face considerable challenges. An alternative approach to direct proteome assessment is to measure transcriptome responses in reporter cells exposed in vitro to plasma. In this report we describe such a " transcriptomic reporter assay" to assess plasma from patients with sepsis, which is a common and severe systemic infectious process for which physicians lack efficient diagnostic or prognostic markers.Methods: Plasma samples collected from patients with culture-confirmed bacterial sepsis and uninfected healthy controls were used to stimulate three separate cell types - neutrophils, peripheral blood mononuclear cells, and monocyte-derived dendritic cells. Whole genome microarrays were generated from stimulated cells to assess transcriptional responses. Unsupervised analysis and enriched functional networks were evaluated for each cell type. Principal component analyses were used to assess variability in responses. A random K-nearest neighbor - feature selection algorithm was used to identify markers predictive of sepsis severity, which were then validated in an independent data set.Results: Neutrophils demonstrated the most distinct response to plasma from septic patients with 709 genes showing altered expression profiles, many of which are involved in established immunologic pathways. The amplitude of the neutrophil transcriptomic response was shown to be correlated with sepsis severity in two independent sets of patients comprised of 64 total septic patients. A subset of 30 transcripts selected using one set of patients was demonstrated to have a high degree of accuracy (82-90%) in predicting sepsis severity and outcomes in the other independent set. This subset included several genes previously established in sepsis pathogenesis as well as novel genes.Conclusions: These results demonstrate both the suitability and potential clinical relevance of a neutrophil reporter assay for studying plasma, in this case from septic patients. The distinctive transcriptional signature we found could potentially help predict severity of disease and guide treatment. Our findings also shed new light on mechanisms of immune dysregulation in sepsis.

Original languageEnglish
Article number65
JournalJournal of Translational Medicine
Volume12
Issue number1
DOIs
Publication statusPublished - 11 Mar 2014
Externally publishedYes

Fingerprint

Assays
Sepsis
Neutrophils
Plasmas
Genes
Proteome
Blood
Genome
Biomarkers
Microarrays
Principal Component Analysis
Transcriptome
Dendritic Cells
Feature extraction
Monocytes
Blood Cells
Technology
Physicians
Molecules
Therapeutics

Keywords

  • Microarray
  • Plasma
  • Sepsis
  • Systems immunology
  • Transcriptomic reporter assay

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma. / Khaenam, Prasong; Rinchai, Darawan; Altman, Matthew C.; Chiche, Laurent; Buddhisa, Surachat; Kewcharoenwong, Chidchamai; Suwannasaen, Duangchan; Mason, Michael; Whalen, Elizabeth; Presnell, Scott; Susaengrat, Wattanachai; O'Brien, Kimberly; Nguyen, Quynh Ahn; Gersuk, Vivian; Linsley, Peter S.; Lertmemongkolchai, Ganjana; Chaussabel, Damien J.

In: Journal of Translational Medicine, Vol. 12, No. 1, 65, 11.03.2014.

Research output: Contribution to journalArticle

Khaenam, P, Rinchai, D, Altman, MC, Chiche, L, Buddhisa, S, Kewcharoenwong, C, Suwannasaen, D, Mason, M, Whalen, E, Presnell, S, Susaengrat, W, O'Brien, K, Nguyen, QA, Gersuk, V, Linsley, PS, Lertmemongkolchai, G & Chaussabel, DJ 2014, 'A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma', Journal of Translational Medicine, vol. 12, no. 1, 65. https://doi.org/10.1186/1479-5876-12-65
Khaenam, Prasong ; Rinchai, Darawan ; Altman, Matthew C. ; Chiche, Laurent ; Buddhisa, Surachat ; Kewcharoenwong, Chidchamai ; Suwannasaen, Duangchan ; Mason, Michael ; Whalen, Elizabeth ; Presnell, Scott ; Susaengrat, Wattanachai ; O'Brien, Kimberly ; Nguyen, Quynh Ahn ; Gersuk, Vivian ; Linsley, Peter S. ; Lertmemongkolchai, Ganjana ; Chaussabel, Damien J. / A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma. In: Journal of Translational Medicine. 2014 ; Vol. 12, No. 1.
@article{739ed22c99e748099511ae40ec377499,
title = "A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma",
abstract = "Background: There are diverse molecules present in blood plasma that regulate immune functions and also present a potential source of disease biomarkers and therapeutic targets. Genome-wide profiling has become a powerful method for assessing immune responses on a systems scale, but technologies that can measure the plasma proteome still face considerable challenges. An alternative approach to direct proteome assessment is to measure transcriptome responses in reporter cells exposed in vitro to plasma. In this report we describe such a {"} transcriptomic reporter assay{"} to assess plasma from patients with sepsis, which is a common and severe systemic infectious process for which physicians lack efficient diagnostic or prognostic markers.Methods: Plasma samples collected from patients with culture-confirmed bacterial sepsis and uninfected healthy controls were used to stimulate three separate cell types - neutrophils, peripheral blood mononuclear cells, and monocyte-derived dendritic cells. Whole genome microarrays were generated from stimulated cells to assess transcriptional responses. Unsupervised analysis and enriched functional networks were evaluated for each cell type. Principal component analyses were used to assess variability in responses. A random K-nearest neighbor - feature selection algorithm was used to identify markers predictive of sepsis severity, which were then validated in an independent data set.Results: Neutrophils demonstrated the most distinct response to plasma from septic patients with 709 genes showing altered expression profiles, many of which are involved in established immunologic pathways. The amplitude of the neutrophil transcriptomic response was shown to be correlated with sepsis severity in two independent sets of patients comprised of 64 total septic patients. A subset of 30 transcripts selected using one set of patients was demonstrated to have a high degree of accuracy (82-90{\%}) in predicting sepsis severity and outcomes in the other independent set. This subset included several genes previously established in sepsis pathogenesis as well as novel genes.Conclusions: These results demonstrate both the suitability and potential clinical relevance of a neutrophil reporter assay for studying plasma, in this case from septic patients. The distinctive transcriptional signature we found could potentially help predict severity of disease and guide treatment. Our findings also shed new light on mechanisms of immune dysregulation in sepsis.",
keywords = "Microarray, Plasma, Sepsis, Systems immunology, Transcriptomic reporter assay",
author = "Prasong Khaenam and Darawan Rinchai and Altman, {Matthew C.} and Laurent Chiche and Surachat Buddhisa and Chidchamai Kewcharoenwong and Duangchan Suwannasaen and Michael Mason and Elizabeth Whalen and Scott Presnell and Wattanachai Susaengrat and Kimberly O'Brien and Nguyen, {Quynh Ahn} and Vivian Gersuk and Linsley, {Peter S.} and Ganjana Lertmemongkolchai and Chaussabel, {Damien J.}",
year = "2014",
month = "3",
day = "11",
doi = "10.1186/1479-5876-12-65",
language = "English",
volume = "12",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma

AU - Khaenam, Prasong

AU - Rinchai, Darawan

AU - Altman, Matthew C.

AU - Chiche, Laurent

AU - Buddhisa, Surachat

AU - Kewcharoenwong, Chidchamai

AU - Suwannasaen, Duangchan

AU - Mason, Michael

AU - Whalen, Elizabeth

AU - Presnell, Scott

AU - Susaengrat, Wattanachai

AU - O'Brien, Kimberly

AU - Nguyen, Quynh Ahn

AU - Gersuk, Vivian

AU - Linsley, Peter S.

AU - Lertmemongkolchai, Ganjana

AU - Chaussabel, Damien J.

PY - 2014/3/11

Y1 - 2014/3/11

N2 - Background: There are diverse molecules present in blood plasma that regulate immune functions and also present a potential source of disease biomarkers and therapeutic targets. Genome-wide profiling has become a powerful method for assessing immune responses on a systems scale, but technologies that can measure the plasma proteome still face considerable challenges. An alternative approach to direct proteome assessment is to measure transcriptome responses in reporter cells exposed in vitro to plasma. In this report we describe such a " transcriptomic reporter assay" to assess plasma from patients with sepsis, which is a common and severe systemic infectious process for which physicians lack efficient diagnostic or prognostic markers.Methods: Plasma samples collected from patients with culture-confirmed bacterial sepsis and uninfected healthy controls were used to stimulate three separate cell types - neutrophils, peripheral blood mononuclear cells, and monocyte-derived dendritic cells. Whole genome microarrays were generated from stimulated cells to assess transcriptional responses. Unsupervised analysis and enriched functional networks were evaluated for each cell type. Principal component analyses were used to assess variability in responses. A random K-nearest neighbor - feature selection algorithm was used to identify markers predictive of sepsis severity, which were then validated in an independent data set.Results: Neutrophils demonstrated the most distinct response to plasma from septic patients with 709 genes showing altered expression profiles, many of which are involved in established immunologic pathways. The amplitude of the neutrophil transcriptomic response was shown to be correlated with sepsis severity in two independent sets of patients comprised of 64 total septic patients. A subset of 30 transcripts selected using one set of patients was demonstrated to have a high degree of accuracy (82-90%) in predicting sepsis severity and outcomes in the other independent set. This subset included several genes previously established in sepsis pathogenesis as well as novel genes.Conclusions: These results demonstrate both the suitability and potential clinical relevance of a neutrophil reporter assay for studying plasma, in this case from septic patients. The distinctive transcriptional signature we found could potentially help predict severity of disease and guide treatment. Our findings also shed new light on mechanisms of immune dysregulation in sepsis.

AB - Background: There are diverse molecules present in blood plasma that regulate immune functions and also present a potential source of disease biomarkers and therapeutic targets. Genome-wide profiling has become a powerful method for assessing immune responses on a systems scale, but technologies that can measure the plasma proteome still face considerable challenges. An alternative approach to direct proteome assessment is to measure transcriptome responses in reporter cells exposed in vitro to plasma. In this report we describe such a " transcriptomic reporter assay" to assess plasma from patients with sepsis, which is a common and severe systemic infectious process for which physicians lack efficient diagnostic or prognostic markers.Methods: Plasma samples collected from patients with culture-confirmed bacterial sepsis and uninfected healthy controls were used to stimulate three separate cell types - neutrophils, peripheral blood mononuclear cells, and monocyte-derived dendritic cells. Whole genome microarrays were generated from stimulated cells to assess transcriptional responses. Unsupervised analysis and enriched functional networks were evaluated for each cell type. Principal component analyses were used to assess variability in responses. A random K-nearest neighbor - feature selection algorithm was used to identify markers predictive of sepsis severity, which were then validated in an independent data set.Results: Neutrophils demonstrated the most distinct response to plasma from septic patients with 709 genes showing altered expression profiles, many of which are involved in established immunologic pathways. The amplitude of the neutrophil transcriptomic response was shown to be correlated with sepsis severity in two independent sets of patients comprised of 64 total septic patients. A subset of 30 transcripts selected using one set of patients was demonstrated to have a high degree of accuracy (82-90%) in predicting sepsis severity and outcomes in the other independent set. This subset included several genes previously established in sepsis pathogenesis as well as novel genes.Conclusions: These results demonstrate both the suitability and potential clinical relevance of a neutrophil reporter assay for studying plasma, in this case from septic patients. The distinctive transcriptional signature we found could potentially help predict severity of disease and guide treatment. Our findings also shed new light on mechanisms of immune dysregulation in sepsis.

KW - Microarray

KW - Plasma

KW - Sepsis

KW - Systems immunology

KW - Transcriptomic reporter assay

UR - http://www.scopus.com/inward/record.url?scp=84897549939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897549939&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-12-65

DO - 10.1186/1479-5876-12-65

M3 - Article

VL - 12

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 65

ER -